Karuna Therapeutics, Inc. (KRTX) has a market capitalization of $12.6B and trades at $329.83. The 52-week range is 158.375-329.99.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -28.1, Earnings Per Share (EPS) of $-11.73, annual revenue of $654K.
The stock has a beta of 1.15, operates in the Healthcare sector.
